Biomarkers

Medically appropriate interventions aimed at preserving physical and cognitive function, supporting healthspan, and addressing measurable age-related decline. We are not promising to reverse aging. We are targeting the specific biological processes that determine how you age.

Cellular and hormonal decline begins accelerating in your 30s, and most therapeutic interventions show the clearest benefit starting in the 40s and 50s, particularly around perimenopause and menopause. Establishing baseline labs earlier gives your provider a reference point that makes future intervention more precise.

The hormonal transition of menopause accelerates bone loss, shifts body composition toward visceral fat, increases cardiovascular risk, and changes how your skin, brain, and metabolism function. These changes are more abrupt than what men experience, which is why women's longevity protocols require a different clinical approach.

Yes. Women have distinct aging patterns driven by reproductive hormone changes, different metabolic responses, and specific health risks that emerge after menopause. Protocols designed around male physiology and adjusted downward don't account for these differences.

Absolutely. Many of these interventions are beneficial regardless of where you are in the aging process. Addressing metabolic health, cellular energy, and hormonal balance after menopause can still meaningfully improve quality of life and long-term health outcomes. Earlier is better, but later still matters.

Yes. Our providers are licensed in Texas, and we can only treat patients who are currently Texas residents. We're working on expanding to additional states.